Table 2.
Biochemical and clinical toxicities after Y-90 radioembolization, evaluated at 3 months posttreatment.
Biochemical and clinical toxicities | Number of patients (%) |
---|---|
ALT (U/L) | |
Grade 1 | 2 (4%) |
Grade 2 | 0 |
Grade 3 | 1 (2%) |
Grade 4 | 0 |
| |
AST (U/L) | |
Grade 1 | 11 (22%) |
Grade 2 | 1 (2%) |
Grade 3 | 1 (2%) |
Grade 4 | 0 |
| |
ALP (U/L) | |
Grade 1 | 26 (53%) |
Grade 2 | 3 (6%) |
Grade 3 | 0 |
Grade 4 | 1 (2%) |
| |
WBC | |
Grade 1 toxicity | 4 (8%) |
Grade 2 toxicity | 1 (2%) |
Grade 3 | 0 |
Grade 4 | 0 |
| |
Bilirubin (μmol/L) | |
Grade 1 toxicity | 5 (10%) |
Grade 2 toxicity | 0 |
Grade 3 | 0 |
Grade 4 | 0 |
| |
Clinical toxicities | |
Fatigue, grade 1 | 2 (4%) |
Abdominal pain, grade 3 | 3 (6%) |
Gastric ulceration, grade 1 | 1 (2%) |
Odynophagia, grade 1 | 1 (2%) |
AST = aspartate aminotransferase; ALT = alanine aminotransferase; ALP = alkaline phosphatase.